Brunswick Corp (BC) stock
BCNYSEEngines & TurbinesFiscal year ends December 31Also trades as BC.PC
Financials through Q3 FY2026, quarter ended Oct 3, 2026Last filing: 10-Q on Nov 5, 2026Score 11/308% above fair value
$78.38−0.04 (-0.05%)
Close on Nov 11, 2026Market cap $5.08BP/E 24.2Yield 2.19%
Earnings
Brunswick's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
Jan 28, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
$1.45B
+6.9% on a year earlier
as adjusted, Q3 FY2026
$1.58
$0.97 a year earlier
Latest guidance
Lowered
Oct 29, 2026 · 6 items
Quarterly results
Revenue and earnings per share from each of Brunswick's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Jan 28, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Oct 3, 2026 | Oct 29, 2026before the open | $1.45B | +6.9% | $1.01 | $1.58 | Release |
| Q2 FY2026ended Jul 4, 2026 | Jul 30, 2026before the open | $1.56B | +7.7% | $1.66 | $1.56 | Release |
| Q1 FY2026ended Apr 4, 2026 | Apr 30, 2026before the open | $1.38B | +12.8% | $0.32 | $0.70 | Release |
| Q4 FY2025ended Dec 31, 2025 | Jan 29, 2026before the open | $1.33B | +15.5% | $0.28 | $0.58 | Release |
| Q3 FY2025ended Sep 27, 2025 | Oct 23, 2025before the open | $1.36B | +6.8% | -$3.57 | $0.97 | Release |
| Q2 FY2025ended Jun 28, 2025 | Jul 24, 2025before the open | $1.45B | +0.2% | $0.90 | $1.16 | Release |
| Q1 FY2025ended Mar 29, 2025 | Apr 24, 2025before the open | $1.22B | -10.5% | $0.30 | $0.56 | Release |
| Q4 FY2024ended Dec 31, 2024 | Jan 30, 2025before the open | $1.15B | -15.2% | -$1.07 | $0.24 | Release |
| Q3 FY2024ended Sep 28, 2024 | Oct 24, 2024before the open | $1.27B | -20.1% | $0.71 | $1.17 | Release |
| Q2 FY2024ended Jun 29, 2024 | Jul 25, 2024before the open | $1.44B | -15.1% | $1.55 | $1.80 | Release |
| Q1 FY2024ended Mar 30, 2024 | Apr 25, 2024before the open | $1.37B | -21.7% | $1.00 | $1.35 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 1, 2024before the open | $1.36B | -14.0% | $1.03 | $1.45 | Release |
| Q3 FY2023ended Sep 30, 2023 | Oct 26, 2023before the open | $1.59B | -6.2% | $1.63 | $2.42 | Release |
| Q2 FY2023ended Jul 1, 2023 | Jul 19, 2023before the open | $1.70B | -7.4% | – | – | Release |
| Q1 FY2023ended Apr 1, 2023 | Apr 27, 2023before the open | $1.74B | +2.8% | $1.56 | $2.57 | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 2, 2023before the open | $1.58B | +10.6% | $1.93 | $1.99 | Release |
| Q3 FY2022ended Oct 1, 2022 | Oct 27, 2022before the open | $1.70B | +19.0% | $2.26 | $2.67 | Release |
| Q2 FY2022ended Jul 2, 2022 | Jul 28, 2022before the open | $1.84B | – | $2.61 | $2.82 | Release |
| Q1 FY2022ended Apr 2, 2022 | Apr 28, 2022before the open | $1.70B | – | $2.25 | $2.53 | Release |
| Q4 FY2021ended Dec 31, 2021 | Jan 27, 2022before the open | $1.43B | – | $1.31 | $1.44 | Release |
| Q3 FY2021ended Oct 2, 2021 | Oct 28, 2021before the open | $1.43B | – | $1.85 | $2.07 | Release |
| Q2 FY2021ended Jul 3, 2021 | Jul 29, 2021before the open | – | – | – | – | Filing |
| Q1 FY2021ended Apr 3, 2021 | Apr 29, 2021before the open | – | – | – | – | Release |
| Q4 FY2020ended Dec 31, 2020 | Jan 28, 2021before the open | – | – | – | – | Filing |
| Q3 FY2020ended Sep 26, 2020 | Oct 29, 2020before the open | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Brunswick's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Net sales | FY2026 | $5.70B – $5.80B | – | New | Oct 29, 2026 |
| Net sales | FY2026 | $5.70B – $5.80B | $5.65B – $5.80B | Raised | Jul 30, 2026 |
| Adjusted operating marginnon-GAAP | FY2026 | 8% | – | New | Oct 29, 2026 |
| Adjusted operating marginnon-GAAP | FY2026 | 8% | 7.5% – 8% | Raised | Jul 30, 2026 |
| Adjusted diluted EPSnon-GAAP | FY2026 | $4.65 | – | New | Oct 29, 2026 |
| Adjusted diluted EPSnon-GAAP | FY2026 | $4.35 – $4.75 | $4.00 – $4.50 | Raised | Jul 30, 2026 |
| Free cash flownon-GAAP | FY2026 | $400.00M | – | New | Oct 29, 2026 |
| Free cash flownon-GAAP | FY2026 | $400.00M | $350.00M | Raised | Jul 30, 2026 |
| Debt retirement | FY2026 | $160.00M | – | New | Oct 29, 2026 |
| Share repurchases | FY2026 | $80.00M | – | Lowered | Oct 29, 2026 |
Guidance vs results
The last range Brunswick gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q3 FY2026 | adjusted diluted EPS | $1.20 – $1.40 | $1.58 | Above range |
| Q3 FY2026 | Revenue | $1.40B – $1.50B | $1.45B | Within range |
| Q2 FY2026 | adjusted diluted EPS | $1.10 – $1.20 | $1.56 | Above range |
| Q2 FY2026 | Revenue | $1.45B – $1.55B | $1.56B | Above range |
| Q1 FY2026 | adjusted diluted EPS | $0.35 – $0.45 | $0.70 | Above range |
| Q1 FY2026 | Revenue | $1.20B – $1.40B | $1.38B | Within range |
| FY2025 | Adjusted diluted EPS | $3.25 | $3.27Σ4Q | Above range |
| FY2025 | Revenue | $5.20B | $5.36BΣ4Q | Above range |
| Q3 FY2025 | adjusted diluted EPS | $0.75 – $0.90 | $0.97 | Above range |
| Q3 FY2025 | Revenue | $1.10B – $1.30B | $1.36B | Above range |
| Q2 FY2025 | adjusted diluted EPS | $0.80 – $1.10 | $1.16 | Above range |
| Q2 FY2025 | Revenue | $1.10B – $1.30B | $1.45B | Above range |
| Q1 FY2025 | adjusted diluted EPS | $0.15 – $0.25 | $0.56 | Above range |
| Q1 FY2025 | Revenue | $1.00B – $1.20B | $1.22B | Above range |
| Q3 FY2024 | adjusted diluted EPS | $1.15 – $1.25 | $1.17 | Within range |
| Q3 FY2024 | Revenue | $1.20B – $1.30B | $1.27B | Within range |
| Q2 FY2024 | adjusted diluted EPS | $1.85 – $2.05 | $1.80 | Below range |
| Q2 FY2024 | Revenue | $1.50B – $1.60B | $1.44B | Below range |
| Q1 FY2024 | adjusted EPS | $1.30 – $1.40 | $1.35 | Within range |
| Q1 FY2024 | Revenue | $1.30B – $1.40B | $1.37B | Within range |
| Q4 FY2023 | adjusted diluted EPS | $1.65 | $1.45 | Below range |
| Q1 FY2023 | adjusted EPS | $2.30 – $2.40 | $2.57 | Above range |
| Q3 FY2022 | EPS | $2.50 – $2.65 | $2.67 | Above range |
Guidance history
Every forecast Brunswick put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Oct 29, 2026 | Adjusted diluted EPS | FY2026 | $4.65 | New |
| Oct 29, 2026 | Free cash flow | FY2026 | $400.00M | New |
| Oct 29, 2026 | Adjusted operating margin | FY2026 | 8% | New |
| Oct 29, 2026 | Debt retirement | FY2026 | $160.00M | New |
| Oct 29, 2026 | Share repurchases | FY2026 | $80.00M | Lowered |
| Oct 29, 2026 | Net sales | FY2026 | $5.70B – $5.80B | New |
| Jul 30, 2026 | Adjusted diluted EPS | FY2026 | $4.35 – $4.75 | Raised |
| Jul 30, 2026 | adjusted diluted EPS | Q3 FY2026 | $1.20 – $1.40 | New |
| Jul 30, 2026 | Free cash flow | FY2026 | $400.00M | Raised |
| Jul 30, 2026 | Adjusted operating margin | FY2026 | 8% | Raised |
| Jul 30, 2026 | Net sales | FY2026 | $5.70B – $5.80B | Raised |
| Jul 30, 2026 | revenue | Q3 FY2026 | $1.40B – $1.50B | New |
| Apr 30, 2026 | Adjusted diluted EPS | FY2026 | $4.00 – $4.50 | Raised |
| Apr 30, 2026 | adjusted diluted EPS | Q2 FY2026 | $1.10 – $1.20 | New |
| Apr 30, 2026 | Free cash flow | FY2026 | $350.00M | Reaffirmed |
| Apr 30, 2026 | Adjusted operating margin | FY2026 | 7.5% – 8% | Reaffirmed |
| Apr 30, 2026 | Net sales | FY2026 | $5.65B – $5.80B | Raised |
| Apr 30, 2026 | revenue | Q2 FY2026 | $1.45B – $1.55B | New |
| Jan 29, 2026 | Adjusted diluted EPS | FY2026 | $3.80 – $4.40 | New |
| Jan 29, 2026 | adjusted diluted EPS | Q1 FY2026 | $0.35 – $0.45 | New |
| Jan 29, 2026 | Free cash flow | FY2026 | $350.00M | New |
| Jan 29, 2026 | Adjusted operating margin | FY2026 | 7.5% – 8% | New |
| Jan 29, 2026 | Net sales | FY2026 | $5.60B – $5.80B | New |
| Jan 29, 2026 | revenue | Q1 FY2026 | $1.20B – $1.40B | New |
| Oct 23, 2025 | Adjusted diluted EPS | FY2025 | $3.25 | New |
| Oct 23, 2025 | free cash flow | FY2025 | $425.00M | New |
| Oct 23, 2025 | Annual share repurchases | FY2025 | $80.00M | New |
| Oct 23, 2025 | Net sales | FY2025 | $5.20B | New |
| Jul 24, 2025 | adjusted diluted EPS | Q3 FY2025 | $0.75 – $0.90 | New |
| Jul 24, 2025 | Adjusted diluted EPS | FY2025 | $3.25 | Narrowed |
| Jul 24, 2025 | Free cash flow | FY2025 | $400.00M | Raised |
| Jul 24, 2025 | revenue | Q3 FY2025 | $1.10B – $1.30B | New |
| Jul 24, 2025 | Net sales | FY2025 | $5.20B | Narrowed |
| Apr 24, 2025 | adjusted diluted EPS | Q2 FY2025 | $0.80 – $1.10 | New |
| Apr 24, 2025 | Adjusted diluted EPS | FY2025 | $2.50 – $4.00 | Lowered |
| Apr 24, 2025 | Free Cash Flow | FY2025 | $350.00M | Reaffirmed |
| Apr 24, 2025 | revenue | Q2 FY2025 | $1.10B – $1.30B | New |
| Apr 24, 2025 | Net sales | FY2025 | $5.00B – $5.40B | Lowered |
| Jan 30, 2025 | adjusted diluted EPS | Q1 FY2025 | $0.15 – $0.25 | New |
| Jan 30, 2025 | Adjusted diluted EPS | FY2025 | $3.50 – $5.00 | New |
| Jan 30, 2025 | Free cash flow | FY2025 | $350.00M | New |
| Jan 30, 2025 | Adjusted operating margin | FY2025 | 7.5% – 9% | New |
| Jan 30, 2025 | revenue | Q1 FY2025 | $1.00B – $1.20B | New |
| Jan 30, 2025 | Net sales | FY2025 | $5.20B – $5.60B | New |
| Oct 24, 2024 | Adjusted diluted EPS | FY2024 | $4.50 | Lowered |
| Oct 24, 2024 | Free Cash Flow | FY2024 | $250.00M | Lowered |
| Oct 24, 2024 | Annual share repurchases | FY2024 | $200.00M | Lowered |
| Oct 24, 2024 | Net sales | FY2024 | $5.10B – $5.20B | Lowered |
| Jul 25, 2024 | adjusted diluted EPS | Q3 FY2024 | $1.15 – $1.25 | New |
| Jul 25, 2024 | Adjusted diluted EPS | FY2024 | $5.00 – $5.50 | Lowered |
| Jul 25, 2024 | Free Cash Flow | FY2024 | $350.00M | Reaffirmed |
| Jul 25, 2024 | Annual share repurchases | FY2024 | $200.00M – $220.00M | Lowered |
| Jul 25, 2024 | net sales | Q3 FY2024 | $1.20B – $1.30B | New |
| Jul 25, 2024 | Net sales | FY2024 | $5.20B – $5.40B | New |
| Apr 25, 2024 | adjusted diluted EPS | Q2 FY2024 | $1.85 – $2.05 | New |
| Apr 25, 2024 | Adjusted diluted EPS | FY2024 | $7.00 – $8.00 | Reaffirmed |
| Apr 25, 2024 | Free Cash Flow | FY2024 | $350.00M | Reaffirmed |
| Apr 25, 2024 | Annual share repurchases | FY2024 | $250.00M | New |
| Apr 25, 2024 | net sales | Q2 FY2024 | $1.50B – $1.60B | New |
| Apr 25, 2024 | Net sales | FY2024 | $6.00B – $6.20B | Reaffirmed |
| Feb 1, 2024 | adjusted EPS | Q1 FY2024 | $1.30 – $1.40 | New |
| Feb 1, 2024 | Adjusted diluted EPS | FY2024 | $7.00 – $8.00 | New |
| Feb 1, 2024 | Free cash flow | FY2024 | $350.00M | New |
| Feb 1, 2024 | Adjusted operating margin | FY2024 | 12% – 13% | New |
| Feb 1, 2024 | revenue | Q1 FY2024 | $1.30B – $1.40B | New |
| Feb 1, 2024 | Net sales | FY2024 | $6.00B – $6.20B | New |
| Oct 26, 2023 | adjusted diluted EPS | Q4 FY2023 | $1.65 | New |
| Oct 26, 2023 | Adjusted diluted EPS | FY2023 | $9.00 | Lowered |
| Oct 26, 2023 | Free Cash Flow | FY2023 | $375.00M | Reaffirmed |
| Oct 26, 2023 | Annual share repurchases | FY2023 | $275.00M | New |
| Oct 26, 2023 | Net sales | FY2023 | $6.45B – $6.50B | New |
| Jul 19, 2023 | Adjusted EPS | FY2023 | $9.50 | Lowered |
| Apr 27, 2023 | adjusted diluted EPS | Q2 FY2023 | $2.60 – $2.70 | New |
| Apr 27, 2023 | Adjusted diluted EPS | FY2023 | $9.50 – $11.00 | Reaffirmed |
| Apr 27, 2023 | Net sales | FY2023 | $6.80B – $7.20B | Reaffirmed |
| Feb 2, 2023 | adjusted EPS | Q1 FY2023 | $2.30 – $2.40 | New |
| Feb 2, 2023 | Adjusted diluted EPS | FY2023 | $9.50 – $11.00 | New |
| Feb 2, 2023 | Free cash flow | FY2023 | $375.00M | New |
| Feb 2, 2023 | Adjusted operating margin | FY2023 | 15% | New |
| Feb 2, 2023 | Net sales | FY2023 | $6.80B – $7.20B | New |
| Oct 27, 2022 | adjusted diluted EPS growth | Q4 FY2022 | +30% | New |
| Oct 27, 2022 | Adjusted diluted EPS | FY2022 | $10.00 | Lowered |
| Oct 27, 2022 | Net sales | FY2022 | $6.90B | Lowered |
| Jul 28, 2022 | EPS | Q3 FY2022 | $2.50 – $2.65 | New |
| Jul 28, 2022 | Adjusted diluted EPS | FY2022 | $10.00 – $10.30 | Raised |
| Jul 28, 2022 | Net sales | FY2022 | $6.90B – $7.10B | Raised |
| Apr 28, 2022 | Adjusted diluted EPS | FY2022 | $9.80 – $10.30 | Raised |
| Apr 28, 2022 | Net sales | FY2022 | $6.80B – $7.10B | Raised |
| Jan 27, 2022 | planned capital spending | FY2022 | $375.00M | New |
| Jan 27, 2022 | Adjusted diluted EPS | FY2022 | $9.60 – $10.25 | New |
| Jan 27, 2022 | Free cash flow | FY2022 | $350.00M | New |
| Jan 27, 2022 | Adjusted operating margin growth | FY2022 | 20 – 60 | New |
| Jan 27, 2022 | Operating expenses as a percent of sales | FY2022 | 50 – 80 | New |
| Jan 27, 2022 | revenue growth | Q1 FY2022 | +15% | New |
| Jan 27, 2022 | Net sales | FY2022 | $6.70B – $7.00B | New |
| Oct 28, 2021 | Adjusted diluted EPS | FY2021 | $8.15 | New |
| Oct 28, 2021 | Free cash flow | FY2021 | $425.00M | New |
| Oct 28, 2021 | Adjusted operating margin growth | FY2021 | +150% – +180% | New |
| Oct 28, 2021 | Net sales | FY2021 | $5.80B | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Brunswick filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- News
- News
- News
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
See a number that looks wrong?